EARLY CD34(HIGH) CELLS CAN BE SEPARATED INTO KITHIGH CELLS IN WHICH TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) DOWN-MODULATES C-KIT AND KITLOW CELLS IN WHICH ANTI-TGF-BETA UPMODULATES C-KIT

被引:47
作者
SANSILVESTRI, P
CARDOSO, AA
BATARD, P
PANTERNE, B
HATZFELD, A
LIM, B
LEVESQUE, JP
MONIER, MN
HATZFELD, J
机构
[1] INST RECH SCI CANC,CNRS,UPR 9044,F-94800 VILLEJUIF,FRANCE
[2] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02215
关键词
D O I
10.1182/blood.V86.5.1729.bloodjournal8651729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously shown that early human CD34(high) hematopoietic progenitors are maintained quiescent in part through autocrine transforming growth factor-beta 1 (TGF-beta 1). We also demonstrated that, in the presence of interleukin-3, interleukin-6, granulocyte colony-stimulating factor, and erythropoietin. TGF-beta 1 antisense oligonucleotides or anti-TGF-beta serum have an additive effect with KIT ligand (Steel factor [SF]), which suggests that they control different pathways of regulation in these conditions. This finding also suggests that autocrine TGF-beta 1 might suppress c-kit expression in primitive human hematopoietic progenitors. We have now distinguished two subpopulations of CD34(high) cells. One subpopulation expresses a c-kit mRNA that can be downmodulated by exogenous TGF-beta 1 within 6 hours. Another subpopulation of early CD34(high) cells expresses a low or undetectable level of c-kit mRNA, but its expression can beupmodulated within 6 hours by anti-TGF-beta. These effects disappear 48 hours after induction and cannot be maintained longer than 72 hours, even if TGF-beta 1 or anti-TGF-beta serum are added every day. Similar kinetics, although delayed, are observed with KIT protein expression. On the contrary, no specific effect of TGF-beta 1 was observed on c-fms, GAPDH, and transferrin receptor gene expression in these early progenitors. These results clarify the complex interaction between TGF-beta 1 and SF in normal early hematopoietic progenitors. SF does not switch off the TGF-beta 1 inhibitory pathway. Autocrine TGF-beta 1 appears to maintain these cells in a quiescent state, suppressing cell division by downmodulating the receptor of SF, a key cytokine costimulator of early progenitors. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:1729 / 1735
页数:7
相关论文
共 26 条
  • [1] BRIDDELL RA, 1992, BLOOD, V79, P3159
  • [2] HUMAN UMBILICAL-CORD BLOOD AS A POTENTIAL SOURCE OF TRANSPLANTABLE HEMATOPOIETIC STEM PROGENITOR CELLS
    BROXMEYER, HE
    DOUGLAS, GW
    HANGOC, G
    COOPER, S
    BARD, J
    ENGLISH, D
    ARNY, M
    THOMAS, L
    BOYSE, EA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) : 3828 - 3832
  • [3] BUHRING HJ, 1991, LEUKEMIA, V5, P854
  • [4] RELEASE FROM QUIESCENCE OF CD34+ CD38- HUMAN UMBILICAL-CORD BLOOD-CELLS REVEALS THEIR POTENTIALITY TO ENGRAFT ADULTS
    CARDOSO, AA
    LI, ML
    BATARD, P
    HATZFELD, A
    BROWN, EL
    LEVESQUE, JP
    SOOKDEO, H
    PANTERNE, B
    SANSILVESTRI, P
    CLARK, SC
    HATZFELD, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8707 - 8711
  • [5] MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) SUPPORTS THE GROWTH OF HUMAN MULTIPOTENTIAL PROGENITOR CELLS WITH A HIGH REPLATING POTENTIAL
    CAROW, CE
    HANGOC, G
    COOPER, SH
    WILLIAMS, DE
    BROXMEYER, HE
    [J]. BLOOD, 1991, 78 (09) : 2216 - 2221
  • [6] IMMUNODETECTION AND QUANTITATION OF THE 2 FORMS OF TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA-1 AND TGF-BETA-2) SECRETED BY CELLS IN CULTURE
    DANIELPOUR, D
    DART, LL
    FLANDERS, KC
    ROBERTS, AB
    SPORN, MB
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 138 (01) : 79 - 86
  • [7] DEVOS S, 1993, CANCER RES, V53, P3638
  • [8] DUBOIS CM, 1994, BLOOD, V83, P3138
  • [9] TRANSFORMING GROWTH-FACTOR-BETA IS A POTENT INHIBITOR OF INTERLEUKIN-1 (IL-1) RECEPTOR EXPRESSION - PROPOSED MECHANISM OF INHIBITION OF IL-1 ACTION
    DUBOIS, CM
    RUSCETTI, FW
    PALASZYNSKI, EW
    FALK, LA
    OPPENHEIM, JJ
    KELLER, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) : 737 - 744
  • [10] GUNJI Y, 1993, BLOOD, V82, P3283